R D Smetanka, G P Lambert, R Murray, D Eddy, M Horn, C V Gisolfi
{"title":"1996年芝加哥马拉松比赛选手的肠通透性。","authors":"R D Smetanka, G P Lambert, R Murray, D Eddy, M Horn, C V Gisolfi","doi":"10.1123/ijsn.9.4.426","DOIUrl":null,"url":null,"abstract":"<p><p>Abdominal cramping, nausea, diarrhea, and GI bleeding are often reported in long-distance runners. This study set out to determine the effects of prolonged (2-4 hrs) exercise and NSAID ingestion on gastric and intestinal permeability during the first 5 hrs following the 1996 Chicago Marathon. Thirty-four healthy volunteers (20 M, 14 F; ages 30-50) completed the race and ingested the test solution (5 g sucrose, 5 g lactulose, 2 g rhamnose, in 40 ml water) within 10-15 min. The urinary excretion ratio of lactulose/rhamnose was used to assess small intestine permeability; sucrose excretion was used to evaluate gastric impairment. There were no significant differences for mean training mileage, postrace rectal temperature, and percent dehydration between runners who ingested NSAIDs and those who did not. In all, 75% of subjects reported aspirin or ibuprofen ingestion before or during the race. Runners who ingested ibuprofen had significant elevations in urinary lactulose excretion and lactulose/rhamnose ratio, whereas those who ingested aspirin or who did not ingest either NSAID had no significant differences in urinary excretion of lactulose, rhamnose, sucrose, or lactulose/rhamnose ratio compared to resting controls. Thirteen of the 26 NSAID users and 4 of the 8 non-users reported GI symptoms. It is concluded that (a) ibuprofen but not aspirin ingestion during prolonged exercise may increase gastrointestinal permeability and lead to GI symptoms, and (b) prolonged exercise alone can produce GI symptoms.</p>","PeriodicalId":14321,"journal":{"name":"International journal of sport nutrition","volume":"9 4","pages":"426-33"},"PeriodicalIF":0.0000,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1123/ijsn.9.4.426","citationCount":"60","resultStr":"{\"title\":\"Intestinal permeability in runners in the 1996 Chicago marathon.\",\"authors\":\"R D Smetanka, G P Lambert, R Murray, D Eddy, M Horn, C V Gisolfi\",\"doi\":\"10.1123/ijsn.9.4.426\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Abdominal cramping, nausea, diarrhea, and GI bleeding are often reported in long-distance runners. This study set out to determine the effects of prolonged (2-4 hrs) exercise and NSAID ingestion on gastric and intestinal permeability during the first 5 hrs following the 1996 Chicago Marathon. Thirty-four healthy volunteers (20 M, 14 F; ages 30-50) completed the race and ingested the test solution (5 g sucrose, 5 g lactulose, 2 g rhamnose, in 40 ml water) within 10-15 min. The urinary excretion ratio of lactulose/rhamnose was used to assess small intestine permeability; sucrose excretion was used to evaluate gastric impairment. There were no significant differences for mean training mileage, postrace rectal temperature, and percent dehydration between runners who ingested NSAIDs and those who did not. In all, 75% of subjects reported aspirin or ibuprofen ingestion before or during the race. Runners who ingested ibuprofen had significant elevations in urinary lactulose excretion and lactulose/rhamnose ratio, whereas those who ingested aspirin or who did not ingest either NSAID had no significant differences in urinary excretion of lactulose, rhamnose, sucrose, or lactulose/rhamnose ratio compared to resting controls. Thirteen of the 26 NSAID users and 4 of the 8 non-users reported GI symptoms. It is concluded that (a) ibuprofen but not aspirin ingestion during prolonged exercise may increase gastrointestinal permeability and lead to GI symptoms, and (b) prolonged exercise alone can produce GI symptoms.</p>\",\"PeriodicalId\":14321,\"journal\":{\"name\":\"International journal of sport nutrition\",\"volume\":\"9 4\",\"pages\":\"426-33\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1123/ijsn.9.4.426\",\"citationCount\":\"60\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International journal of sport nutrition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1123/ijsn.9.4.426\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of sport nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1123/ijsn.9.4.426","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 60
摘要
长跑运动员经常出现腹部绞痛、恶心、腹泻和胃肠道出血。本研究旨在确定1996年芝加哥马拉松比赛后的前5小时内,长时间(2-4小时)运动和非甾体抗炎药摄入对胃肠通透性的影响。健康志愿者34名(M 20, F 14;年龄30-50岁)在10-15分钟内完成比赛并摄入试验溶液(5 g蔗糖,5 g乳果糖,2 g鼠李糖,40 ml水中)。用尿中乳果糖/鼠李糖的排泄比来评估小肠通透性;蔗糖排泄用于评价胃损伤。在服用非甾体抗炎药和未服用非甾体抗炎药的跑步者之间,平均训练里程、赛后直肠温度和脱水百分比没有显著差异。总的来说,75%的受试者报告在比赛前或比赛中服用了阿司匹林或布洛芬。服用布洛芬的跑步者尿中乳果糖排泄量和乳果糖/鼠李糖比值显著升高,而服用阿司匹林或未服用非甾体抗炎药的跑步者尿中乳果糖、鼠李糖、蔗糖或乳果糖/鼠李糖比值与静息对照相比没有显著差异。26名非甾体抗炎药使用者中的13名和8名非使用者中的4名报告了胃肠道症状。结论是:(a)长时间运动时摄入布洛芬而非阿司匹林可增加胃肠道通透性并导致胃肠道症状;(b)长时间运动本身可产生胃肠道症状。
Intestinal permeability in runners in the 1996 Chicago marathon.
Abdominal cramping, nausea, diarrhea, and GI bleeding are often reported in long-distance runners. This study set out to determine the effects of prolonged (2-4 hrs) exercise and NSAID ingestion on gastric and intestinal permeability during the first 5 hrs following the 1996 Chicago Marathon. Thirty-four healthy volunteers (20 M, 14 F; ages 30-50) completed the race and ingested the test solution (5 g sucrose, 5 g lactulose, 2 g rhamnose, in 40 ml water) within 10-15 min. The urinary excretion ratio of lactulose/rhamnose was used to assess small intestine permeability; sucrose excretion was used to evaluate gastric impairment. There were no significant differences for mean training mileage, postrace rectal temperature, and percent dehydration between runners who ingested NSAIDs and those who did not. In all, 75% of subjects reported aspirin or ibuprofen ingestion before or during the race. Runners who ingested ibuprofen had significant elevations in urinary lactulose excretion and lactulose/rhamnose ratio, whereas those who ingested aspirin or who did not ingest either NSAID had no significant differences in urinary excretion of lactulose, rhamnose, sucrose, or lactulose/rhamnose ratio compared to resting controls. Thirteen of the 26 NSAID users and 4 of the 8 non-users reported GI symptoms. It is concluded that (a) ibuprofen but not aspirin ingestion during prolonged exercise may increase gastrointestinal permeability and lead to GI symptoms, and (b) prolonged exercise alone can produce GI symptoms.